17 days ago
TEVA
AnalystsChris SchottChris Schott's Stock Forecasts
AnalystsChris Schott
Analyst Ranking
Top 14%
#692 out of 5164 analysts
Average Return
+10%
Win Rate
66%54 out of 82
Risk vs Reward
Poor
Good
Chris Schott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +85.30% | $395.86 | $733.51 | 2023-04-28 - 2024-04-26 | Strong Buy |
Eli Lilly & CoLLY | +75.50% | $458.48 | $804.62 | 2023-07-28 - 2024-07-26 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +73.78% | $17.96 | $31.21 | 2025-05-12 - 2025-12-31 | Strong Buy |
Kala Bio IncKALA | +73.24% | $205.50 | $356.00 | 2019-11-08 - 2020-11-06 | Strong Buy |
Eli Lilly & CoLLY | +71.77% | $625.65 | $1,074.68 | 2025-08-08 - 2025-12-31 | Strong Buy |
Chris Schott Analyst Color
Get additional color on Chris Schott's coverage of popular stocks
a month ago
LLY
2 months ago
TEVA
2 months ago
ABBV
2 months ago
GILD
3 months ago
TEVA
4 months ago
GILD
4 months ago
LLY
4 months ago
AMRX
4 months ago
ABBV
5 months ago
LLY
5 months ago
IDXX
8 months ago
TEVA
10 months ago
AMRX
a year ago
LLY
a year ago
LLY
2 years ago
LLY
2 years ago
PFE
2 years ago
LLY
2 years ago
LLY
3 years ago
LLY
3 years ago
LLY
Chris Schott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | 10 | Strong Buy | $35.00 | +12.14% | Maintains | 17 days ago |
Perrigo Co PLCPRGO | 7 | Hold | $18.00 | +29.31% | Maintains | 18 days ago |
Eli Lilly & CoLLY | 15 | Strong Buy | $1,150.00 | +7.01% | Maintains | a month ago |
Organon & CoOGN | 3 | Strong Sell | $12.00 | +67.36% | Maintains | 2 months ago |
Zoetis IncZTS | 3 | Strong Buy | $200.00 | +58.96% | Maintains | 2 months ago |
Idexx Laboratories IncIDXX | 9 | Strong Buy | $775.00 | +14.56% | Maintains | 2 months ago |
Abbvie IncABBV | 4 | Strong Buy | $260.00 | +13.79% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 8 | Strong Buy | $150.00 | +22.21% | Maintains | 2 months ago |
Elanco Animal Health IncELAN | 4 | Strong Buy | $24.00 | +6.05% | Upgrades | 3 months ago |
Amneal Pharmaceuticals IncAMRX | 3 | Strong Buy | $14.00 | +11.11% | Maintains | 4 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $800.00 | +3.64% | Maintains | 7 months ago |
Biogen IncBIIB | 4 | Hold | $175.00 | -0.56% | Maintains | 8 months ago |
Royalty Pharma PLCRPRX | 4 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Amgen IncAMGN | 1 | Hold | $270.00 | N/A | Reinstates | 2 years ago |
Pfizer IncPFE | 3 | Hold | $34.00 | N/A | Maintains | 2 years ago |
Merck & Co IncMRK | 4 | Strong Buy | $125.00 | N/A | Maintains | 3 years ago |
Viatris IncVTRS | 2 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Coherus Oncology IncCHRS | 2 | Hold | $11.00 | N/A | Maintains | 3 years ago |
Eqrx IncEQRX | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Heska CorpHSKA | 2 | Strong Buy | $150.00 | N/A | Maintains | 3 years ago |
Bausch Health Companies IncBHC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 5 years ago |
Kala Bio IncKALA | 4 | Strong Buy | $950.00 | N/A | Maintains | 6 years ago |
Endo International PLCENDPQ | 2 | Hold | $10.00 | N/A | Maintains | 7 years ago |
Pacira Biosciences IncPCRX | 2 | Hold | $50.00 | N/A | Maintains | 7 years ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $74.00 | N/A | Maintains | 7 years ago |
Therapeuticsmd IncTXMD | 1 | Strong Buy | $550.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.